Clinical Trials
10 trialsNCT07586826 2026-05-14
N01-A-PICIT-GT
Peking University People's Hospital
Phase 2 Recruiting
NCT03344965 2026-01-05
Olaparib In Metastatic Breast Cancer
Beth Israel Deaconess Medical Center
Phase 2 Active not recruiting
NCT05485766 2025-03-20
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
Okayama University
Phase 2 Recruiting
NCT00494234 2024-01-19
ICEBERG 1
AstraZeneca
Phase 2 Completed
NCT04477616 2023-02-23
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT02685111 2020-07-31
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
Asan Medical Center
Phase 2 Terminated
NCT02005458 2018-07-17
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 2 Completed
NCT01569087 2016-12-05
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Biocad
Phase 2 Completed
NCT02119715 2014-04-22
A Phase II Study Comparing Pegylated rhG-CSF(HHPG-19K) and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT00120692 2007-12-24
Treatment for Patients Suffering From Anemia Due to Chemotherapy
Amgen
Phase 2 Completed